Cohort Study on Appropriate Strategies of The Rapid Build of HIV Related Protective Barriers in Yunnan, China
Overview
- Phase
- Not Applicable
- Intervention
- The dosage of 400mg EFV
- Conditions
- Viral Suppression of HIV Infection
- Sponsor
- National Center for AIDS/STD Control and Prevention, China CDC
- Enrollment
- 600
- Locations
- 2
- Primary Endpoint
- Viral suppression of HIV-infected patients
- Last Updated
- 7 years ago
Overview
Brief Summary
The purpose of the study is to screen the optimal intervention strategies to rapid establish the protective barriers against HIV-infection by maximally decreasing the viremia among HIV- infected patients.
Detailed Description
Sexual transmission became the primary route of HIV transmission in China and heterosexual transmission also contributed greatly to HIV epidemic which was mostly reported in South-west rural areas. In past years, Yunnan has experienced powerful campaign of scaling-up the HIV identification as well as antrertroviral therapy. This study will investigate how to reach the last two of HIV'90-90-90 targets': to provide antiretroviral therapy (ART) for 90% of who diagnosed HIV infection and to achieve viral suppression for 90% of those treated. The study population consists of participants who received an newly diagnosed HIV infection within the study period. All rerolled participants will be randomized into different study group. In intervention group, medical institutions will provide patients personal involved intervention strategies which guided by frequent viral load detection, and providing of the dosage form of 400 mg EFV in their antiviral therapy. Main assessment measures are viral suppression rate of HIV-infected patients and treatment coverage .
Investigators
Eligibility Criteria
Inclusion Criteria
- •HIV-positive participants who received an newly diagnosed HIV infection within the study period
- •Having a current residential address inside of pilot site limits
- •Eighteen years old or above
- •HIV transmission is heterosexual contact
Exclusion Criteria
- •Having severe mental disorder
Arms & Interventions
medicine intervention group
The dosage of 400 mg EFV will be used in the antiviral therapy.
Intervention: The dosage of 400mg EFV
consolidated intervention group
Medical institutions will provide personal involved intervention strategies as well as the providing of dosage form of 400 mgEFV in their antiviral therapy.
Intervention: Personal involved intervention strategies
consolidated intervention group
Medical institutions will provide personal involved intervention strategies as well as the providing of dosage form of 400 mgEFV in their antiviral therapy.
Intervention: The dosage of 400mg EFV
Outcomes
Primary Outcomes
Viral suppression of HIV-infected patients
Time Frame: 12 months
Secondary Outcomes
- Treatment coverage(12 months)